{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:30:39Z","timestamp":1792690239146,"version":"4.5.0"},"reference-count":27,"publisher":"BMJ","issue":"10","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2019,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background\/Aim<\/jats:title>\n                    <jats:p>Fractionated conformal radiotherapy (FCRT) is now used to treat vision-threatening optic nerve sheath meningioma (ONSM), but long-term efficacy and safety data are lacking; the purpose of this study was to assess these key data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is a retrospective chart review with prospective follow-up of adult patients treated with FCRT for primary ONSM at four academic medical centres between 1995 and 2007 with \u226510 years of follow-up after treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>16 patients were identified with a mean post-treatment follow-up of 14.6 years (range: 10.5\u201320.7 years). The mean age at symptom onset was 47.6 years (range: 36\u201360 years). FCRT was performed at a mean of 2.3 years after symptom onset (range: 0.2\u201314.0 years). At last follow-up, visual acuity had improved or stabilised in 14 of the 16 (88%) patients, and 11 (69%) had retained or achieved \u226520\/40. The mean deviation on automated perimetry remained stable (\u221214.5 dB pretreatment vs \u221212.2 dB at last follow-up; p=0.68, n=10). Two (11%) patients had persistent pain, proptosis or diplopia, compared with six (38%) pretreatment (p=0.11). Two (13%) patients developed radiation retinopathy more than 6 months after completion of therapy, one (50%) of whom had worse visual acuity compared with pretreatment. No patient developed tumour involvement or radiation damage in the fellow eye.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>FCRT stabilises or improves visual function in patients with primary ONSM and is associated with a low risk of significant ocular sequelae. This treatment should be considered instead of surgery in patients with primary ONSM who require intervention due to loss of visual sensory and\/or ocular motor function.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bjophthalmol-2018-313135","type":"journal-article","created":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T17:25:02Z","timestamp":1545326702000},"page":"1436-1440","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":24,"title":["Long-term efficacy of fractionated conformal radiotherapy for the management of primary optic nerve sheath meningioma"],"prefix":"10.1136","volume":"103","author":[{"given":"Ravi","family":"Pandit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Paris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle S","family":"Rudich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L","family":"Lesser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J","family":"Kupersmith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil R","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,12,20]]},"reference":[{"key":"2020050713022491000_103.10.1436.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2012.02.010"},{"key":"2020050713022491000_103.10.1436.2","doi-asserted-by":"publisher","DOI":"10.1016\/0039-6257(92)90135-G"},{"key":"2020050713022491000_103.10.1436.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(02)01017-5"},{"key":"2020050713022491000_103.10.1436.4","first-page":"85","article-title":"Radiation therapy for primary optic nerve meningiomas","volume":"1","author":"Smith","year":"1981","journal-title":"J Clin Neuroophthalmol"},{"key":"2020050713022491000_103.10.1436.5","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/01.wno.0000235569.19131.ac","article-title":"New concepts in the diagnosis and management of optic nerve sheath meningioma","volume":"26","author":"Miller","year":"2006","journal-title":"J Neuroophthalmol"},{"key":"2020050713022491000_103.10.1436.6","doi-asserted-by":"crossref","first-page":"168-74","DOI":"10.47102\/annals-acadmedsg.V35N3p168","article-title":"New concepts in the management of optic nerve sheath meningiomas","volume":"35","author":"Berman","year":"2006","journal-title":"Ann Acad Med Singapore"},{"key":"2020050713022491000_103.10.1436.7","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2009.167346"},{"key":"2020050713022491000_103.10.1436.8","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1102\/1470-7330.2004.0003","article-title":"Intensity-modulated radiotherapy--what is it?","volume":"4","author":"Taylor","year":"2004","journal-title":"Cancer Imaging"},{"key":"2020050713022491000_103.10.1436.9","doi-asserted-by":"publisher","DOI":"10.1097\/00006123-200205000-00006"},{"key":"2020050713022491000_103.10.1436.10","doi-asserted-by":"publisher","DOI":"10.1097\/00006123-200210000-00007"},{"key":"2020050713022491000_103.10.1436.11","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.86.11.1265"},{"key":"2020050713022491000_103.10.1436.12","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.ijrobp.2010.11.018","article-title":"Fractionated Stereotactic Radiotherapy in Patients With Optic Nerve Sheath Meningioma","volume":"82","author":"Paulsen","year":"2012","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"key":"2020050713022491000_103.10.1436.13","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0360-3016(03)00005-1","article-title":"Preliminary visual outcomes after three-dimensional conformal radiation therapy for optic nerve sheath meningioma","volume":"56","author":"Narayan","year":"2003","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"key":"2020050713022491000_103.10.1436.14","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/01.WNO.0000165105.78365.22","article-title":"The visual impact of fractionated stereotactic conformal radiotherapy on seven eyes with optic nerve sheath meningiomas","volume":"25","author":"Landert","year":"2005","journal-title":"J Neuroophthalmol"},{"key":"2020050713022491000_103.10.1436.15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/IOP.0000000000000914","article-title":"Visual Outcomes and Local Control After Fractionated Stereotactic Radiotherapy for Optic Nerve Sheath Meningioma","volume":"34","author":"Hamilton","year":"2018","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"2020050713022491000_103.10.1436.16","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.prro.2012.06.010","article-title":"Radiation therapy for optic nerve sheath meningioma","volume":"3","author":"Brower","year":"2013","journal-title":"Pract Radiat Oncol"},{"key":"2020050713022491000_103.10.1436.17","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.ijrobp.2008.12.056","article-title":"Visual Outcome and Tumor Control After Conformal Radiotherapy for Patients With Optic Nerve Sheath Meningioma","volume":"75","author":"Arvold","year":"2009","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"key":"2020050713022491000_103.10.1436.18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijrobp.2010.01.034","article-title":"Fractionated Conformal Radiotherapy for Management of Optic Nerve Sheath Meningiomas: Long-Term Outcomes of Tumor Control and Visual Function at a Single Institution","volume":"80","author":"Metellus","year":"2011","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"key":"2020050713022491000_103.10.1436.19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/WNO.0b013e318267fc5e","article-title":"Untreated bilateral optic nerve sheath meningiomas observed for 27 years","volume":"33","author":"Kothari","year":"2013","journal-title":"J Neuroophthalmol"},{"key":"2020050713022491000_103.10.1436.20","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2017-310672"},{"key":"2020050713022491000_103.10.1436.21","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.clon.2013.02.004","article-title":"Radiotherapy for optic nerve sheath meningioma: a case for earlier intervention?","volume":"25","author":"Adams","year":"2013","journal-title":"Clin Oncol"},{"key":"2020050713022491000_103.10.1436.22","unstructured":"Monteiro MLR . OCT and Compressive Optic Neuropathy. In: OCT in Central Nervous System Diseases. Cham: Springer International Publishing, 2016: 69\u201386."},{"key":"2020050713022491000_103.10.1436.23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1167\/tvst.6.3.19","article-title":"Aqueous Deficient Dry Eye Syndrome Post Orbital Radiotherapy: A 10-Year Retrospective Study","volume":"6","author":"Tiwari","year":"2017","journal-title":"Transl Vis Sci Technol"},{"issue":"Suppl 1","key":"2020050713022491000_103.10.1436.24","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.21037\/cco.2017.06.08","article-title":"Radiation for skull base meningiomas: review of the literature on the approach to radiotherapy","volume":"6","author":"Moraes","year":"2017","journal-title":"Chin Clin Oncol"},{"key":"2020050713022491000_103.10.1436.25","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1748-717X-6-36","article-title":"Fractionated stereotactic conformal radiotherapy for large benign skull base meningiomas","volume":"6","author":"Minniti","year":"2011","journal-title":"Radiat Oncol"},{"key":"2020050713022491000_103.10.1436.26","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/cncr.22859","article-title":"Primary optic nerve sheath meningioma","volume":"110","author":"Jeremic","year":"2007","journal-title":"Cancer"},{"key":"2020050713022491000_103.10.1436.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2003.06.025"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2018-313135","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T06:42:08Z","timestamp":1694500928000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2018-313135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,20]]},"references-count":27,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,9,19]]},"published-print":{"date-parts":[[2019,10]]}},"alternative-id":["10.1136\/bjophthalmol-2018-313135"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2018-313135","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.734675175.793559249","asserted-by":"object"}]},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,20]]}}}